1 – 7 of 7
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers
(
- Contribution to journal › Article
- 2012
-
Mark
Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
(
- Contribution to journal › Article
- 2011
-
Mark
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer : Preliminary analysis of the results of the IMPACT study
(
- Contribution to journal › Article
-
Mark
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(
- Contribution to journal › Article
- 2008
-
Mark
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
(
- Contribution to journal › Article
- 2005
-
Mark
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
(
- Contribution to journal › Article
- 1999
-
Mark
Guidelines for follow-up of women at high risk for inherited breast cancer : consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
(
- Contribution to journal › Article